<bill session="113" type="h" number="3089" updated="2013-11-02T06:45:01-04:00">
  <state datetime="2013-09-12">REFERRED</state>
  <status>
    <introduced datetime="2013-09-12"/>
  </status>
  <introduced datetime="2013-09-12"/>
  <titles>
    <title type="short" as="introduced">Compounding Clarity Act of 2013</title>
    <title type="official" as="introduced">To amend section 503A of the Federal Food, Drug, and Cosmetic Act with respect to pharmacy compounding.</title>
  </titles>
  <sponsor id="412485"/>
  <cosponsors>
    <cosponsor id="400101" joined="2013-09-12"/>
    <cosponsor id="400137" joined="2013-09-16"/>
    <cosponsor id="400160" joined="2013-09-12"/>
    <cosponsor id="412280" joined="2013-09-16"/>
    <cosponsor id="400179" joined="2013-09-20"/>
    <cosponsor id="412255" joined="2013-09-18"/>
  </cosponsors>
  <actions>
    <action datetime="2013-09-12" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Advisory bodies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health care quality"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
</bill>
